2024-12-29 10:02:04
Certa Therapeutics' investigational drug FT011 delivers breakthrough results as a potential novel treatment for serious inflammatory and fibrotic diseases
Health/ 2023-07-22
Certa Therapeutics' investigational...

Research presented today by University of Michigan Medical School highlights FT011\'s ground-breaking treatment potential from human express...

Daewoong Pharmaceutical Presents Phase 3 Clinical Trial Results of New Diabetes Treatment 'Enavogliflozin' and Roadmap to Enter 50 Countries by 2030
Corporate/ 2023-07-24
Daewoong Pharmaceutical Presents Phase 3...

Highly anticipated to be an effectivetherapeutic for its excellent efficacies in reducing blood glucose levels and safety

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release